References
- White AM, Slater ME, Ng G, Hingson R, Breslow R. Trends in alcohol-related emergency department visits in the United States: results from the nationwide emergency department sample, 2006 to 2014. Alcohol Clin Exp Res. 2018;42:352–59. doi:https://doi.org/10.1111/acer.13559.
- Thomson AD, Cook CC, Touquet R, Henry JA. Royal college of physicians, London. The royal college of physicians report on alcohol: guidelines for managing Wernicke’s encephalopathy in the accident and emergency department. Alcohol Alcohol. 2002;37:513–21. doi:https://doi.org/10.1093/alcalc/37.6.513.
- Galvin R, Bråthen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA. EFNS. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010;17:1408–18. doi:https://doi.org/10.1111/j.1468-1331.2010.03153.x.
- Pruckner N, Baumgartner J, Hinterbuchinger B, Glahn A, Vyssoki S, Vyssoki B. Thiamine substitution in alcohol use disorder: a narrative review of medical guidelines. Eur Addict Res. 2019;25:103–10. doi:https://doi.org/10.1159/000499039.
- Sechi G, Serra A. Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007;6:442–55. doi:https://doi.org/10.1016/S1474-4422(07)70104-7.
- Sinha S, Kataria A, Kolla BP, Thusius N, Loukianova LL. Wernicke encephalopathy-clinical pearls. Mayo Clin Proc. 2019;94:1065–72. doi:https://doi.org/10.1016/j.mayocp.2019.02.018.
- Whitfield KC, Bourassa MW, Adamolekun B, Bergeron G, Bettendorff L, Brown KH, Cox L, Fattal-Valevski A, Fischer PR, Frank EL, et al. Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs. Ann N Y Acad Sci. 2018;1430:3–43.
- Arts NJM, Pitel AL, Kessels RPC. The contribution of mamillary body damage to Wernicke’s encephalopathy and Korsakoff’s syndrome. Handb Clin Neurol. 2021;180:455–75.
- Sullivan EV, Pfefferbaum A. Neuroimaging of the Wernicke-Korsakoff syndrome. Alcohol Alcohol. 2009;44:155–65. doi:https://doi.org/10.1093/alcalc/agn103.
- Donnino MW, Vega J, Miller J, Walsh M. Myths and misconceptions of Wernicke’s encephalopathy: what every emergency physician should know. Ann Emerg Med. 2007;50:715–21. doi:https://doi.org/10.1016/j.annemergmed.2007.02.007.
- Thomson AD, Cook CC, Guerrini I, Sheedy D, Harper C, Marshall EJ. Wernicke’s encephalopathy: ‘Plus ça change, plus c’est la même chose’. Alcohol Alcohol. 2008;4:180–86. doi:https://doi.org/10.1093/alcalc/agm149.
- Torvik A, Lindboe CF, Rogde S. Brain lesions in alcoholics. A neuropathological study with clinical correlations. J Neurol Sci. 1982;56:233–48. doi:https://doi.org/10.1016/0022-510X(82)90145-9.
- Peck NM, Bania TC, Chu J. Low rates of thiamine prescribing in adult patients with alcohol-related diagnoses in the emergency department. Am J Drug Alcohol Abuse. 2021;47:704–10.
- Schuckit MA. Alcohol-use disorders. Lancet. 2009;373:492–501. doi:https://doi.org/10.1016/S0140-6736(09)60009-X.
- Day E, Bentham PW, Callaghan R, Kuruvilla T, George S. Thiamine for prevention and treatment of Wernicke-Korsakoff syndrome in people who abuse alcohol. Cochrane Database Syst Rev. 2013;2013(7):CD004033.
- McLaughlin K, Joyal K, Lee S, Corrado M, Marquis K, Anger K, Szumita P. Safety of intravenous push thiamine administration at a tertiary academic medical center. J Am Pharm Assoc (2003). 2020;60:598–601. doi:https://doi.org/10.1016/j.japh.2019.12.005.
- Thomson A, Guerrini I, Marshall EJ. Incidence of adverse reactions to parenteral thiamine in the treatment of Wernicke’s encephalopathy, and recommendations. Alcohol Alcohol. 2019;54:609–14. doi:https://doi.org/10.1093/alcalc/agy091.
- Tjugum SL, Hedrick TL, Jean SJ, Heeney SA, Rohde KA, Campbell-Bright SL. Evaluation of the safety of intravenous thiamine administration in a large academic medical center. J Pharm Pract. 2021;34:397–402. doi:https://doi.org/10.1177/0897190019872584.
- Witkiewitz K, Litten RZ, Leggio L. Advances in the science and treatment of alcohol use disorder. Sci Adv. 2019;5:eaax4043. doi:https://doi.org/10.1126/sciadv.aax4043.
- Roerecke M, Gual A, Rehm J. Reduction of alcohol consumption and subsequent mortality in alcohol use disorders: systematic review and meta-analyses. J Clin Psychiatry. 2013;74:e1181–e1189. doi:https://doi.org/10.4088/JCP.13r08379.
- Roerecke M, Rehm J. Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction. 2013;108:1562–78. doi:https://doi.org/10.1111/add.12231.
- Han B, Jones CM, Einstein EB, Powell PA, Compton WM. Use of medications for alcohol use disorder in the US: results from the 2019 national survey on drug use and health. JAMA Psychiatry. 2021;78(8):922–924.
- Nunes EV, Kunz K, Galanter M, O’Connor PG. Addiction psychiatry and addiction medicine: the evolution of addiction physician specialists. Am J Addict. 2020;29:390–400. doi:https://doi.org/10.1111/ajad.13068.
- Volkow ND, Gordon JA, Koob GF. Choosing appropriate language to reduce the stigma around mental illness and substance use disorders. Neuropsychopharmacology. Forthcoming.